GuARDS

Our research project will perform extra scans and blood tests to see if we can identify underlying heart disease which may benefit from treatment. This treatment will be with commonly used medications, known to be beneficial in the treatment of patients with heart attacks due to a blocked artery. We hope to prevent patients with type 2 myocardial infarction having a future heart attack and prolong their life by improving their medical care.

Chief Investigator: Manu Shankar-Hari

Number and location of participating sites (by region/country): N/A

EudraCT number: N/A

ISRCTN number: N/A

Funder: NIHR HTA

 

Start and End date

Of grant award: 06 January 2023 - 31 May 2028

Of recruitment N/A

 

Current Status: Open    

 

UK GDPR privacy statement: UK GDPR statement provided at consent

 

Website links: GuARDS Trial | Centre for Inflammation Research

 

ECTU Involvement:  Health Economics/ Statistics / Data Management & Programming

This article was published on